Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 66531

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 22, 2013
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Sandoz Incorporated

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01

D-383-2014
Recall number
D-383-2014
Initiated
October 22, 2013
Classification
Class II
Status
Terminated
Recalling firm
Sandoz Incorporated
Quantity
12,521 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

Code information

Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14

Distribution pattern

Nationwide